← All organizations
Groupe Hospitalier Paris Saint Joseph
Academic/HospitalWebsite ↗
Also known as: CH Paris Saint Joseph - Paris | Groupe Hospitalier Paris Saint Joseph | Groupe Hospitalier Paris Saint-Joseph (FRANCE) | Groupe Hospitalier Saint Joseph | IFCT | IFCT, GH Paris Saint-Joseph | IFCT, HCL Lyon-Sud
Highest phase reached
Phase 3
First clinical trial
May 1, 2001Last known activity
Oct 13, 2020
Timeline
1870s
- Jun 1, 1878
Groupe Hospitalier Paris Saint Joseph— Founded
Drugs by trial phase (36 distinct, 18 trials)
Phase 3 (14 own, 0 via acquisition)
Phase 2 (19 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Recent trials (21)
- NCT04529278Lead sponsorPhase 2Oct 13, 2020
- NCT04365582Overall official - principal investigatorPhase 3Apr 28, 2020
- NCT04365582Lead sponsorPhase 3Apr 28, 2020
- NCT03903783Overall official - principal investigatorN/AApr 30, 2019
- NCT03903783Lead sponsorN/AApr 30, 2019
- NCT03543436CollaboratorPhase 3Jul 31, 2018
- NCT02876081Lead sponsorPhase 2Dec 1, 2016
- NCT02716272Overall official - principal investigatorPhase 2Apr 1, 2016
- NCT02778828Lead sponsorN/ADec 10, 2015
- NCT02778828Overall official - principal investigatorN/ADec 10, 2015
- NCT02117167CollaboratorPhase 2Apr 23, 2014
- NCT01952223Overall official - principal investigatorPhase 3Sep 1, 2013
- NCT01443065Overall official - principal investigatorPhase 2Jan 1, 2011
- NCT01102231Overall official - principal investigatorPhase 2Mar 1, 2010
- NCT00651456Study directorPhase 2/Phase 3Feb 1, 2008
Details
- Founded
- Paris, FR Jun 1, 1878
- Last known activity
- Oct 13, 2020